1. CMU Intellectual Repository

Browsing by Author Constance A. Benson

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
15-Oct-2015Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T. Podany; Yajing Bao; Susan Swindells; Richard E. Chaisson; Janet W. Andersen; Thando Mwelase; Khuanchai Supparatpinyo; Lerato Mohapi; Amita Gupta; Constance A. Benson; Peter Kim; Courtney V. Fletcher
1-Apr-2022A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S. Solomon; Sandra Wagner-Cardoso; Laura Smeaton; Leonard A. Sowah; Chanelle Wimbish; Gregory Robbins; Irena Brates; Christine Scello; Annie Son; Anchalee Avihingsanon; Benjamin Linas; Donald Anthony; Estevão Portela Nunes; Dimas A. Kliemann; Khuanchai Supparatpinyo; Cissy Kityo; Pablo Tebas; Jaclyn Ann Bennet; Jorge Santana-Bagur; Constance A. Benson; Marije Van Schalkwyk; Nelson Cheinquer; Susanna Naggie; David Wyles; Mark Sulkowski
14-Mar-2019One month of rifapentine plus isoniazid to prevent HIV-related TuberculosisSusan Swindells; Ritesh Ramchandani; Amita Gupta; Constance A. Benson; Jorge Leon-Cruz; Noluthando Mwelase; Marc A. Jean Juste; Javier R. Lama; Javier Valencia; Ayotunde Omoz-Oarhe; Khuanchai Supparatpinyo; Gaerolwe Masheto; Lerato Mohapi; Rodrigo O. Da Silva Escada; Sajeeda Mawlana; Peter Banda; Patrice Severe; James Hakim; Cecilia Kanyama; Deborah Langat; Laura Moran; Janet Andersen; Courtney V. Fletcher; Eric Nuermberger; Richard E. Chaisson
1-Jan-2020Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapineDavid W. Haas; Anthony T. Podany; Yajing Bao; Susan Swindells; Richard E. Chaisson; Noluthando Mwelase; Khuanchai Supparatpinyo; Lerato Mohapi; Amita Gupta; Constance A. Benson; Paxton Baker; Courtney V. Fletcher
1-Sep-2022Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based DosingMichelle M. Pham; Anthony T. Podany; Noluthando Mwelase; Khuanchai Supparatpinyo; Lerato Mohapi; Amita Gupta; Wadzanai Samaneka; Ayotunde Omoz-Oarhe; Deborah Langat; Constance A. Benson; Richard E. Chaisson; Susan Swindells; Courtney V. Fletcher
Showing results 1 to 5 of 5